SCHEMBL6201377

SCHEMBL6201377

C=CCOc1cc[c]cc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.47
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
FLT3 P36888 1/20 0.41
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 1/20 0.41
KDM4E B2RXH2 3/20 0.40
BLM P54132 1/20 0.40
CYP3A4 P08684 1/20 0.37
CASP1 P29466 1/20 0.35
POLB P06746 2/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SLC22A1 O15245 1/20 0.34
CYP1A2 P05177 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6198183 0.84 KMT2A (0.34) GAATSHRKDM4EPOLBLMNA
SCHEMBL6198186 0.84 KMT2A (0.34) GAATSHRKDM4EPOLBLMNA
SCHEMBL6198842 0.84 TSHR (0.56) LIG1GAATSHRFLT3ADRB2
SCHEMBL4284044 0.82 KMT2A (0.50) GAATSHRKDM4ECYP3A4CASP1
SCHEMBL6200854 0.81 CHEK1 (0.41) GAATSHRKDM4ELMNANPSR1
SCHEMBL6195388 0.80 KMT2A (0.38) TSHRKDM4ECYP3A4POLBLMNA
SCHEMBL6199939 0.79 KMT2A (0.52) GAATSHRKDM4EPOLBLMNA
SCHEMBL30195826 0.79 LIG1 (0.68) LIG1GAATSHRADRB2ADRB1
SCHEMBL385145 0.79 LIG1 (0.68) LIG1GAATSHRADRB2ADRB1
SCHEMBL21268183 0.78 CYP1A2 (0.44) GAATSHRKDM4ECYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed